文献速递肝胆胰外科围术期管理与 ERAS

肝术后早期血清磷酸盐下降可预测充分的肝脏肥大

Early Postoperative Serum Phosphate Drop Predicts Sufficient Hypertrophy After Liver Surgery.
PubMed 文献 · Ann Surg · 2023-07-19

该研究前瞻性评估ALPPS(n=61)和活体肝移植(LLD,n=54)术后7天内血清磷酸盐变化与1周后标准化体积测量的相关性,并辅以小鼠和体外实验。结果显示,术后磷酸盐显著下降且与肝脏肥大程度相关(P<0.001),下降幅度低的ALPPS患者术后肝衰竭发生率更高(7% vs 31%,P=0.041)。

要点

  • 肝切除术后早期血清磷酸盐下降与肝脏肥大程度显著相关。
  • ALPPS术后磷酸盐下降幅度低的患者术后肝衰竭发生率更高。
  • 围术期监测血清磷酸盐有助于早期识别再生能力不足的患者。

核心结论

  • 肝切除术后磷酸盐下降是肝脏肥大的直接替代标志物。
  • 围术期实施血清磷酸盐分析有可能早期发现再生能力不足的患者。

研究设计与样本

  • 前瞻性评估ALPPS(n=61)和活体肝移植(LLD,n=54)术后7天内血清磷酸盐变化,并与1周后标准化体积测量进行相关性分析。
  • 转化研究:在小鼠ALPPS和肝切除模型以及体外实验中探讨术后磷酸盐变化。

主要发现

  • ALPPS第一阶段和LLD术后,血清磷酸盐从术前中位数1.08 mmol/L(IQR 0.92-1.23)和1.07 mmol/L(IQR 0.91-1.21)分别显著下降至术后中位最低值0.68 mmol/L和0.52 mmol/L。
  • 明显的磷酸盐下降与肝脏肥大增加良好相关(P<0.001)。
  • 磷酸盐下降幅度低的ALPPS患者术后肝衰竭发生率更高(7% vs 31%,P=0.041)。
  • 在小鼠ALPPS和肝切除模型中,磷酸盐下降与肥大程度显著相关(P<0.001)。
  • 体外阻断磷酸盐转运体(Slc20a1)可抑制细胞磷酸盐摄取和肝细胞增殖。

临床怎么用

  • 围术期可考虑监测血清磷酸盐,以早期识别肝切除术后再生能力不足的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to assess the impact of postoperative hypophosphatemia on liver regeneration after major liver surgery in the scenario of Associating Liver Partition with Portal vein ligation for Staged hepatectomy (ALPPS) and living liver donation (LLD). BACKGROUND: Hypophosphatemia has been described to reflect the metabolic demands of regenerating hepatocytes. Both ALPPS and LLD are characterized by an exceptionally strong liver regeneration and may be of particular interest in the context of posthepatectomy hypophosphatemia. METHODS: Serum phosphate changes within the first 7 postoperative days after ALPPS (n=61) and LLD (n=54) were prospectively assessed and correlated with standardized volumetry after 1 week. In a translational approach, postoperative phosphate changes were investigated in mice and in vitro . RESULTS: After ALPPS stage 1 and LLD, serum phosphate levels significantly dropped from a preoperative median of 1.08 mmol/L [interquartile range (IQR) 0.92-1.23] and 1.07 mmol/L (IQR 0.91-1.21) to a postoperative median nadir of 0.68 and 0.52 mmol/L, respectively. A pronounced phosphate drop correlated well with increased liver hypertrophy ( P <0.001). Patients with a low drop of phosphate showed a higher incidence of posthepatectomy liver failure after ALPPS (7% vs 31%, P =0.041). Like in humans, phosphate drop correlated significantly with degree of hypertrophy in murine ALPPS and hepatectomy models ( P <0.001). Blocking phosphate transporter (Slc20a1) inhibited cellular phosphate uptake and hepatocyte proliferation in vitro. CONCLUSION: Phosphate drop after hepatectomy is a direct surrogate marker for liver hypertrophy. Perioperative implementation of serum phosphate analysis has the potential to detect patients with insufficient regenerative capacity at an early stage.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Kambakamba P, Schneider MA, Linecker M, et al. Early Postoperative Serum Phosphate Drop Predicts Sufficient Hypertrophy After Liver Surgery. Ann Surg. 2023. PMID: 37465990. doi:10.1097/SLA.0000000000006013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。